Spectroscopy and serial diffusion MR findings in hGH-Creutzfeldt-Jakob disease

被引:27
作者
Oppenheim, C
Zuber, M
Galanaud, D
Detilleux, M
Bolgert, F
Mas, JL
Chiras, J
Meder, JF
机构
[1] St Anne Hosp, Dept Neuroimaging, F-75014 Paris, France
[2] St Anne Hosp, Dept Neurol, F-75014 Paris, France
[3] Hop La Pitie Salpetriere, Dept Neuroradiol, F-75013 Paris, France
[4] Cochin Port Royal Hosp, Dept Internal Med, F-75013 Paris, France
[5] Hop La Pitie Salpetriere, Intens Care Unit, Paris, France
关键词
D O I
10.1136/jnnp.2003.020172
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
This report describes the magnetic resonance imaging (MRI) findings in two patients fulfilling the diagnostic criteria for human growth hormone Creutzfeldt-Jakob disease, who initially had pronounced bilateral DWI/FLAIR (diffusion weighted imaging/fluid attenuated inversion recovery) hyperintensities in the basal ganglia, with decreased apparent diffusion coefficient ( ADC) values (range, 58-82% of normal). MRI spectroscopy, obtained in one case, showed decreased N-acetyl aspartate/creatine (NAA/Cr) ratio in the atrophic vermis (0.79; normal: mean, 1.20; SD, 0.13), despite the lack of DWI/FLAIR signal changes, whereas NAA/Cr was normal in the putamina (1.6; normal: mean, 1.56; SD, 0.17), despite striking DWI signal changes and decreased ADC values (60% of normal). Serial DWI, obtained in the other case, showed a progressive disappearance of DWI hypersignal of the basal ganglia replaced by pronounced atrophy. Data from these two patients suggest that restricted diffusion associated with a normal NAA value might indicate spongiform changes of still viable cells, and that any subsequent regression of the DWI signal changes, atrophy, or decreased NAA values could be related to progressive neuronal death.
引用
收藏
页码:1066 / 1069
页数:4
相关论文
共 24 条
[1]   Brain magnetic resonance diffusion abnormalities in Creutzfeldt-Jakob disease [J].
Bahn, MM ;
Kido, DK ;
Lin, WL ;
Pearlman, AL .
ARCHIVES OF NEUROLOGY, 1997, 54 (11) :1411-1415
[2]   Abnormal diffusion-weighted magnetic resonance images in Creutzfeldt-Jakob disease [J].
Bahn, MM ;
Parchi, P .
ARCHIVES OF NEUROLOGY, 1999, 56 (05) :577-583
[3]   Changes in N-acetylaspartate and myo-inositol detected in the cerebral cortex of hamsters with Creutzfeldt-Jakob disease [J].
Behar, KL ;
Boucher, R ;
Fritch, W ;
Manuelidis, L .
MAGNETIC RESONANCE IMAGING, 1998, 16 (08) :963-968
[4]   INVIVO MONITORING OF NEURONAL LOSS IN CREUTZFELDT-JAKOB DISEASE BY PROTON MAGNETIC-RESONANCE SPECTROSCOPY [J].
BRUHN, H ;
WEBER, T ;
THORWIRTH, V ;
FRAHM, J .
LANCET, 1991, 337 (8757) :1610-1611
[5]   Iatrogenic Creutzfeldt-Jakob disease following human growth hormone therapy - Case report [J].
Caboclo, LOSF ;
Huang, N ;
Lepski, GA ;
Livramento, JA ;
Buchpiguel, CA ;
Porto, CS ;
Nitrini, R .
ARQUIVOS DE NEURO-PSIQUIATRIA, 2002, 60 (2B) :458-461
[6]   Accuracy of diffusion-weighted MR imaging in the diagnosis of sporadic Creutzfeldt-Jakob disease [J].
Demaerel, P ;
Sciot, R ;
Robberecht, W ;
Dom, R ;
Vandermeulen, D ;
Maes, F ;
Wilms, G .
JOURNAL OF NEUROLOGY, 2003, 250 (02) :222-225
[7]  
DEVILLEMEUR TB, 1994, NEUROPATH APPL NEURO, V20, P111
[8]  
Galanaud D, 2002, J NEURORADIOLOGY, V29, P285
[9]   Regional metabolite levels of the normal posterior fossa studied by proton chemical shift imaging [J].
Galanaud, D ;
Le Fur, Y ;
Nicoli, F ;
Denis, W ;
Confort-Gouny, S ;
Ranjeva, JP ;
Viout, P ;
Pelletier, J ;
Cozzone, PJ .
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE, 2001, 13 (02) :127-133
[10]   PROTON MAGNETIC-RESONANCE SPECTROSCOPY IN CREUTZFELDT-JAKOB-DISEASE [J].
GRAHAM, GD ;
PETROFF, OAC ;
BLAMIRE, AM ;
RAJKOWSKA, G ;
GOLDMANRAKIC, P ;
PRICHARD, JW .
NEUROLOGY, 1993, 43 (10) :2065-2068